From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?

Abstract

Suicide gene therapy is a relatively novel form of cancer therapy in which a gene coding for enzymes or protein toxins is delivered through targeting systems such as vesicles, nanoparticles, peptide or lipidic co-adjuvants. The use of toxin genes is particularly interesting since their catalytic activity can induce cell death, damaging in most cases the translation machinery (ribosomes or protein factors involved in protein synthesis) of quiescent or proliferating cells. Thus, toxin gene delivery appears to be a promising tool in fighting cancer. In this review we will give an overview, describing some of the bacterial and plant enzymes studied so far for their delivery and controlled expression in tumor models.

Keywords

• suicide gene therapy (SGT)
• cancer
• nanoparticles (NPs)
• extracellular vesicles
• toxins
• plant ribosome inactivating protein (RIP)